In a World First, a Patient’s Antibody Cells Were Just Genetically Engineered

from What's New · host WIRED

B cells are prolific producers of antibodies, but for the first time, scientists have modified them to make other proteins to counteract a serious genetic disease. Thanks for listening to WIRED. Talk to you next time for more stories from WIRED.com and read this story here. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Episode metadata supplied by the publisher feed · Published Dec 18, 2023

Embed this episode

Attribution link and audio player

Ready to play

In a World First, a Patient’s Antibody Cells Were Just Genetically Engineered

0:00 8:55

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

CISO Perspectives (public) N2K Networks This season on CISO Perspectives, host Kim Jones explores some of the challenges of leading through uncertainty. We explore the complexity of the changing nature of regulation and working with the federal government, the evolution of privacy and fraud, and how emerging technologies like AI and quantum computing are changing cyber. When you don’t know what questions to ask, you’re afraid to ask, or don’t know who to ask, CISO Perspectives provides the foundation for learning in this brave new world.

Frequently Asked Questions

How long is this episode of What's New?

This episode is 8 minutes long.

When was this What's New episode published?

This episode was published on December 18, 2023.

Can I download this What's New episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!